Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Regulatory review of drugs and devices: Aligned reviews for certain drugs - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 256556
Later capture
Regulatory review of drugs and devices: Aligned reviews for certain drugs - Canada.ca
Jan 2, 2026
hc-20260101
ID 428606
updated2 sections changed
2 sections changed0 added0 removed+0 / -3 linesChange ratio: 9%
--- +++ @@ -1,6 +1,4 @@ Aligned reviews for certain drugs-From:-Health Canada The Health Canada and Health Technology Assessment (HTA) review processes are independent of each other. This project will make sure that the timing of Health Canada and Canadian HTA reviews are better aligned, while facilitating information sharing between Health Canada and HTA organizations. Examples of Canadian organizations that do HTAs include the: Canadian Agency for Drugs and Technologies in Health (CADTH)@@ -14,5 +12,4 @@ developing an Implementation Plan (completed June 2018) All parts of this project are now fully implemented, and we continue to collect best practices to improve project processes. Page details-Date modified: 2019-07-17